New Search

If you are not happy with the results below please do another search

57 search results for: lgc capital

1

LGC Capital Completes $8 Million Bought-Deal Private Placement

Montreal, Québec – February 16, 2018 – LGC Capital Ltd. (TSXV: LG) (“LGC“) is pleased to announce that it has completed its previously-announced bought-deal private placement, including a partial exercise of the underwriter’s option, by issuing 18,515,000 units at a price of $0.435 per unit for gross proceeds to LGC of $8,054,025.  The units were sold to “accredited investors” […]

2

LGC Capital Increases Strategic Interest in Australian Medical Cannabis Company – Little Green Pharma

MONTREAL, Feb. 15, 2018 – LGC Capital Ltd. (TSXV: LG) (“LGC“) is pleased to announce that it yesterday completed its previously-announced transaction with licenced Australian Medical Cannabis company Habi Pharma Pty Ltd of Perth, Australia, doing business as Little Green Pharma (“Little Green Pharma“), whereby LGC increased its strategic interest in Little Green Pharma to 14.99% from 11.91%. John McMullen, CEO of LGC […]

3

LGC Capital Completes US$2.34 Million Convertible Loan Transaction to Fund Business Expansion

MONTREAL, Feb. 8, 2018 – LGC Capital Ltd. (TSXV: LG) (“LGC“) is pleased to announce that it has now completed its previously-announced transaction with international investors YA II PN, Ltd and Cuart Investments PCC Limited pursuant to which they loaned an aggregate amount of US $2.34 million (approximately CAD $2.94 million) to LGC at a closing held today. John McMullen, LGC Capital’s CEO commented; “LGC intends to use […]

4

LGC Capital Ltd. Receives TSX Venture Exchange Approval for US $2.34 Million Convertible Loan Agreement

Montreal, Québec – January 31, 2018 – LGC Capital Ltd. (TSXV: LG) (“LGC”) is pleased to announce that it has received conditional approval from the TSX Venture Exchange for its previously-announced transaction with international investors YA II PN, Ltd and Cuart Investments PCC Limited pursuant to which they will loan LGC an aggregate amount of US $2.34 million (approximately CAD $2.88 million).  LGC […]

5

LGC Capital to Expand Global Footprint in Medical Cannabis Market Through Investment in Jamaica’s Global Canna Labs Limited

LGC to subscribe for a $2.5 million secured debenture of Jamaican cannabis company Global Canna Labs Limited, convertible into an initial 30% interest, and to acquire a 5% royalty on net sales. The Jamaican Cannabis Licensing Authority granted Global Canna Labs conditional approval for a Cultivator’s Licence (Tier 3) (over 5 acres) on December 20, 2017. […]

6

LGC Capital to Increase Strategic Interest in Australian Medical Cannabis Company – Little Green Pharma

LGC to increase its strategic interest in Australian Medical Cannabis company Little Green Pharma to 14.99% by issuing 5,000,000 LGC shares. Australian Government to allow the export of medicinal cannabis exports. MONTREAL, Jan. 22, 2018 – LGC Capital Ltd. (TSXV: LG) (“LGC“) is pleased to announce that it has entered into a Binding Term Sheet with licenced Australian Medical […]

7

Interview With LGC Capital CEO John McMullen – “LGC Is the Only Pure Global Play In The Canadian Market”

Over the weekend John McMullen, CEO of LGC Capital, was interviewed by Steve Feldman on his Vancouver radio show “Canada Pot Talks”. During the over 20 minute interview, Mr. McMullen covered the following topics. LGC’s unique global approach to the cannabis market. An overview of LGC’s Australian grower – Little Green Pharma. Mr. Feldman mentioned […]

8

LGC Capital Closes Investment Into Quebec-Based Future Medicinal Cannabis Grower AAA Trichomes

MONTREAL, Jan. 8, 2018 – LGC Capital Ltd. (TSXV: LG) (“LGC“) is pleased to announce that it has successfully finalized the transaction with Québec-based Tricho-Med Corporation (doing business as “AAA Trichomes”). As reported in prior news releases, LGC entered into a four-year secured convertible loan agreement with AAA Trichomes in an amount of $4 million CDN (the “Loan”), which will be […]

9

LGC Capital Clarifies it is an Investor in the Global Cannabis Market, Excluding the United States

MONTREAL, January 5, 2018 – LGC Capital Ltd. (TSXV: LG) (“LGC”) wishes to comment on the directive issued yesterday by the United States Justice Department that will allow the enforcement of U.S. federal marijuana laws in those states that have legalized cannabis. John McMullen, CEO of LGC stated: “As a Canadian, I have full respect […]

10

LGC Capital Ltd. Enters Into US $2.34 Million Convertible Loan Agreement To Fund 2018 Expansion

Montreal, Québec – January 2, 2018 – LGC Capital Ltd. (TSXV: LG) (“LGC”) is pleased to announce that it has entered into an Investment Agreement with international investors YA II PN, Ltd and Cuart Investments PCC Limited pursuant to which they will loan LGC an aggregate amount of US $2.34 million (approximately CAD $2.94 million). […]

11

LGC Capital provides positive update on House of Hemp (Pty) Ltd in South Africa with Support from Dube TradePort and Trade & Investment KwaZulu-Natal

MONTREAL, Dec. 20, 2017 – LGC Capital Ltd. (TSXV: LG) (“LGC”) is pleased to provide the positive update regarding LGC’s ongoing due diligence currently conducted on the proposed 60% acquisition of the House of Hemp (Pty) Ltd (“House of Hemp”) in South Africa, under the agreements previously announced on July 18, 2017, and the onsite inspection of the 424,000 square feet of fully […]

12

LGC Capital Ltd. Increases Interest in Australian Medical Cannabis Company and Little Green Pharma Plants First Commercial Crop

MONTREAL, Dec. 14, 2017  – LGC Capital Ltd. (TSXV: LG) (“LGC“) is pleased to announce that it has now received confirmation from the Australian Government’s Office of Drug Control to increase its interest in licenced Australian Medical Cannabis company Habi Pharma Pty Ltd of Perth, Australia, doing business as Little Green Pharma (“Little Green Pharma“), above 4.99% and is now increasing […]

13

LGC Capital Ltd. Grants Stock Options and Amends 2016 Stock Option Plan

MONTREAL, Dec. 11, 2017 – LGC Capital Ltd. (TSXV: LG) (“LGC“) announces that on December 8, 2017, its Board of Directors granted an aggregate of 5,250,000 stock options to six of LGC’s directors and officers.  The stock options have an exercise price of $0.36, representing the closing price of LGC’s shares on the TSX Venture Exchange on December 7, 2017, and a term of […]

14

LGC Capital Receives Conditional Approval for AAA Trichomes Transaction

MONTREAL, Dec. 6, 2017  – As per previously announced press release on October 31st, LGC Capital Ltd. (TSXV: LG) (“LGC“) is pleased to announce that the TSX Venture Exchange has conditionally approved LGC’s proposed transaction with Québec-based Tricho-Med Corporation (doing business as AAA Trichomes). LGC wishes to report that its due diligence review of AAA Trichomes has been completed, all major deal […]